Tommaso Cassano
Tommaso Cassano
Verified email at unifg.it
Title
Cited by
Cited by
Year
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6452005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6452005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6452005
Aberrant insulin signaling in Alzheimer's disease: current knowledge
G Bedse, F Di Domenico, G Serviddio, T Cassano
Frontiers in neuroscience 9, 204, 2015
1842015
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors
MG Morgese, T Cassano, V Cuomo, A Giuffrida
Experimental neurology 208 (1), 110-119, 2007
1632007
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery
A Trapani, E De Giglio, D Cafagna, N Denora, G Agrimi, T Cassano, ...
International journal of pharmaceutics 419 (1-2), 296-307, 2011
1522011
Nonmotor symptoms in Parkinson's disease: Investigating early‐phase onset of behavioral dysfunction in the 6‐hydroxydopamine‐lesioned rat model
I Branchi, I D'Andrea, M Armida, T Cassano, A Pezzola, RL Potenza, ...
Journal of neuroscience research 86 (9), 2050-2061, 2008
1142008
Nonmotor symptoms in Parkinson's disease: Investigating early‐phase onset of behavioral dysfunction in the 6‐hydroxydopamine‐lesioned rat model
I Branchi, I D'Andrea, M Armida, T Cassano, A Pezzola, RL Potenza, ...
Journal of neuroscience research 86 (9), 2050-2061, 2008
1142008
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin
S Gaetani, J Fu, T Cassano, P Dipasquale, A Romano, L Righetti, ...
Journal of Neuroscience 30 (24), 8096-8101, 2010
1062010
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
A Seillier, T Advani, T Cassano, JG Hensler, A Giuffrida
International Journal of Neuropsychopharmacology 13 (3), 373-386, 2010
982010
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus
FR Bambico, T Cassano, S Dominguez-Lopez, N Katz, CD Walker, ...
Neuropsychopharmacology 35 (10), 2083-2100, 2010
952010
Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changesá…
T Antonelli, MC Tomasini, M Tattoli, T Cassano, S Tanganelli, S Finetti, ...
Cerebral cortex 15 (12), 2013-2020, 2005
912005
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats
V Trezza, P Campolongo, T Cassano, T Macheda, P Dipasquale, ...
Psychopharmacology 198 (4), 529-537, 2008
902008
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
T Cassano, G Serviddio, S Gaetani, A Romano, P Dipasquale, S Cianci, ...
Neurobiology of aging 33 (6), 1121. e1-1121. e12, 2012
882012
Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease
L Trabace, T Cassano, L Steardo, C Pietra, G Villetti, KM Kendrick, ...
Journal of Pharmacology and Experimental Therapeutics 294 (1), 187-194, 2000
842000
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs
S Gaetani, P Dipasquale, A Romano, L Righetti, T Cassano, D Piomelli, ...
International review of neurobiology 85, 57-72, 2009
742009
PRECLINICAL STUDY: Perinatal exposure to delta‐9‐tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression andá…
P Campolongo, V Trezza, T Cassano, S Gaetani, MG Morgese, M Ubaldi, ...
Addiction biology 12 (3‐4), 485-495, 2007
702007
Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target
T Cassano, S Calcagnini, L Pace, F De Marco, A Romano, S Gaetani
Frontiers in neuroscience 11, 30, 2017
632017
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease
G Bedse, A Romano, AM Lavecchia, T Cassano, S Gaetani
Journal of Alzheimer's Disease 43 (4), 1115-1136, 2015
602015
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice
T Cassano, S Gaetani, T Macheda, L Laconca, A Romano, MG Morgese, ...
Psychopharmacology 214 (2), 465-476, 2011
602011
The system can't perform the operation now. Try again later.
Articles 1–20